According to a new market report published by Lucintel, the future of the diagnostic specialty enzyme market looks promising with opportunities in pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts. The global diagnostic specialty enzyme market is expected to grow with a CAGR of 8% from 2020 to 2025. The major drivers for this market are increase in the use of enzymes in biotech & diagnostic applications; a surge in investment; rise in prevalence of chronic, infectious, and lifestyle diseases; and early and instant diagnosis of life threatening diseases.
To download report brochure, please go to https://www.lucintel.com/diagnostic-specialty-enzyme-market.aspx and click "download brochure" tab from the menu
Enzymes are biological molecules or typically proteins that significantly speed up the reaction time of virtually all of the chemical reactions that occur within cells. They act as biological catalysts. In this market, protease, carbohydrases, polymerases and nucleases, and lipase are the major product types. Lucintel forecasts that polymerases and nucleases will remain the largest product segment over the forecast period due to rise in the usage of polymerase and nuclease enzymes in advanced biotech applications, such as DNA sequencing and DNA amplification.
Within this market, pharmaceuticals will remain the largest application segment over the forecast period due to increasing incorporation of enzymes in therapies for diseases, such as cancer, cardiovascular diseases, lysosomal storage disorders, and pain and inflammation management.
North America will remain the largest region over the forecast period due to increase in adoption of new biotechnology technologies, such as next generation sequencing, and significant research spending in overall national budgets.
F. Hoffmann-La Roche, Novozymes, Codexis, Amano Enzyme, Advanced Enzyme Technologies, Affymetrix, DuPont, BASF, Life Technologies, and Sanofi are among the major suppliers in the global diagnostic specialty enzyme market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global diagnostic specialty enzyme market by product, source, application, form, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Diagnostic Specialty Enzyme Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global diagnostic specialty enzyme market by product, source, application, form, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Protease
Carbohydrases
Polymerases and Nucleases
Lipase
By Source [Value ($ Million) shipment analysis for 2014 – 2025]:
Microorganisms
Plants
Animals
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceuticals
Research & Biotechnology
Diagnostics
Biocatalysts
By Form [Value ($ Million) shipment analysis for 2014 – 2025]:
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.